DFIN’s three‑month outperformance (+9.5 points vs. the S&P) is notable because it demonstrates the stock’s ability to cushion downside during acute market stress, which may signal underlying business stability that investors can leverage if broader conditions improve.
The 3‑year annualized underperformance of -5.8% still represents a negative return; if the company’s growth initiatives falter or regulatory changes compress pricing power, investors could see returns revert to the index trend, potentially eroding the current 20.5‑point relative edge.
The 3.25% drop in institutional holdings translates to roughly $15 million (based on a market cap near $460 M), indicating that some large investors are trimming exposure, which could presage further downward pressure if the trend accelerates.
The negative 1.9% YoY revenue change, coupled with a -2.7% three‑year CAGR, signals a structural sales erosion that challenges the company's growth narrative and necessitates a strategic pivot to restore top‑line expansion.
The net margin of only 4.2% translates to roughly $32 M of profit on $767 M revenue; a further 5% revenue decline would cut net income by about $16 M, potentially driving the company into operating loss and jeopardizing cash flow sustainability.
The 55% contraction in net profit margin is the dominant driver of ROE decline, signaling that core profitability has deteriorated and cannot be compensated solely by increased leverage.
| Year | ROE% | Margin% | Turnover | Leverage | ROIC% | ROCE% | ROA% |
|---|---|---|---|---|---|---|---|
| 2025 | 8.5 | 4.2 | 0.96 | 2.11 | 28.8 | 25.2 | 4.0 |
| 2024 | 21.2 | 11.8 | 0.91 | 1.97 | 26.9 | 22.6 | 10.8 |
| 2023 | 20.4 | 10.3 | 0.99 | 2.01 | 22.6 | 19.8 | 10.2 |
| 2022 | 31.1 | 12.3 | 1.01 | 2.51 | 28.1 | 25.3 | 12.4 |
| 2021 | 38.7 | 14.7 | 1.12 | 2.34 | 39.0 | 35.3 | 16.5 |
| 2020 | -10.5 | -2.9 | 1.00 | 3.63 | 0.6 | 0.5 | -2.9 |
| 2019 | 14.0 | 4.3 | 0.99 | 3.30 | 11.9 | 11.1 | 4.2 |
| 2018 | 32.6 | 7.6 | 1.11 | 3.84 | 19.6 | 18.1 | 8.5 |
| 2017 | 6.5 | 1.0 | 1.12 | 5.98 | 14.8 | 13.5 | 1.1 |
| 2016 | 53.2 | 6.0 | 1.00 | 8.81 | 14.6 | 13.2 | 6.0 |
| 2015 | 16.7 | 9.9 | 1.28 | 1.31 | 26.2 | 24.9 | 12.8 |
The combination of a 4.2% profit margin and a 37‑day cash conversion cycle means operating cash flow is vulnerable; a 10% increase in days sales outstanding would cut free cash flow by roughly $15M, jeopardizing the firm’s ability to service debt.
| Year | Total Asset Days | Inventory Days | Receivables Days | Fixed Asset Days | Payables Days | Cash Conversion Cycle |
|---|---|---|---|---|---|---|
| 2025 | 381 | 0 | 68 | 8 | 31 | 37 |
| 2024 | 400 | 5 | 64 | 10 | 35 | 35 |
| 2023 | 369 | 0 | 70 | 14 | 37 | 32 |
| 2022 | 363 | 8 | 72 | 22 | 49 | 31 |
| 2021 | 325 | 5 | 73 | 23 | 32 | 46 |
| 2020 | 367 | 4 | 71 | 26 | 40 | 35 |
| 2019 | 370 | 7 | 67 | 41 | 39 | 35 |
| 2018 | 329 | 8 | 66 | 12 | 45 | 28 |
| 2017 | 325 | 14 | 60 | 13 | 40 | 34 |
| 2016 | 363 | 14 | 94 | 13 | 50 | 58 |
| 2015 | 284 | 13 | 51 | 11 | 23 | 41 |
| Year | Total Assets | Total Liabilities | Total Equity | Total Debt | Net Debt | Cash | Current Assets | Current Liabilities |
|---|---|---|---|---|---|---|---|---|
| 2025 | $800M | $421M | $379M | $182M | $157M | $24M | $211M | $200M |
| 2024 | $857M | $421M | $436M | $144M | $87M | $57M | $232M | $224M |
| 2023 | $807M | $405M | $402M | $153M | $130M | $23M | $208M | $202M |
| 2022 | $828M | $499M | $330M | $216M | $182M | $34M | $228M | $225M |
| 2021 | $883M | $506M | $377M | $187M | $133M | $54M | $280M | $261M |
| 2020 | $899M | $651M | $248M | $301M | $228M | $74M | $267M | $238M |
| 2019 | $887M | $618M | $269M | $376M | $359M | $17M | $211M | $180M |
| 2018 | $869M | $643M | $226M | $363M | $315M | $47M | $249M | $198M |
| 2017 | $894M | $744M | $149M | $458M | $406M | $52M | $270M | $187M |
| 2016 | $979M | $868M | $111M | $587M | $551M | $36M | $330M | $186M |
| 2015 | $818M | $194M | $624M | $38M | $23M | $15M | $191M | $124M |
| Year | Operating CF | Investing CF | Financing CF | CapEx | Free Cash Flow | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| 2025 | $165M | $-57M | $-142M | $-57M | $108M | $-185M | |
| 2024 | $171M | $-53M | $-82M | $-66M | $105M | $-82M | |
| 2023 | $124M | $-51M | $-85M | $-62M | $62M | $-40M | |
| 2022 | $150M | $-51M | $-121M | $-54M | $96M | $-165M | |
| 2021 | $180M | $-45M | $-155M | $-42M | $138M | $-41M | |
| 2020 | $154M | $-20M | $-78M | $-31M | $123M | $-12M | |
| 2019 | $54M | $-12M | $-74M | $-45M | $10M | $-2M | |
| 2018 | $66M | $30M | $-99M | $-37M | $29M | $-2M | |
| 2017 | $91M | $-31M | $-46M | $-28M | $64M | $-1M | |
| 2016 | $106M | $-29M | $-60M | $-26M | $80M | ||
| 2015 | $121M | $-37M | $-95M | $-27M | $94M |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-06-08 · finexus.net